This group also showed decreased expression of Bcl-xL, CDK4/6, c-MYC, IL-7R, p-STAT5, and PIM1, and increased expression of BIM, HEXIM1, and p21 in BET inhibitor treated AML cells from sAML. This evidence concerns the gene DNER and acute myeloid leukemia.